To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research into intra-nasal covid-19 vaccines.

The Department commissions research through the National Institute for Health Research (NIHR). The NIHR and UK Research and Innovation have funded rapid research to support the response to the COVID-19 pandemic, including on nasal administration of vaccines. Approximately £580,000 in funding was awarded to Imperial College London towards a study looking at safety and lower airway immunogenicity of two candidate COVID-19 vaccines administered to the respiratory tract. Additionally, the NIHR is providing infrastructure support to two phase one studies in this area, including the study at Imperial College London. As the largest public funder of health and care research, the NIHR welcomes funding applications for research into any aspect of human health, including intra-nasal COVID-19 vaccines.